Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00232180
Status:
COMPLETED
Last Update Posted:
2020-12-22
First Post:
2005-09-30
Brief Title:
A Comparison Of Outcomes In Patients In New York Heart Association NYHA Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines
Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization:
Pfizer